Viewing Study NCT04204850


Ignite Creation Date: 2025-12-24 @ 5:24 PM
Ignite Modification Date: 2026-01-04 @ 8:18 AM
Study NCT ID: NCT04204850
Status: RECRUITING
Last Update Posted: 2025-12-03
First Post: 2019-12-17
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Cabozantinib to Treat Recurrent Liver Cancer Post Transplant
Sponsor: University Health Network, Toronto
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module